When did GeneDx Holdings report Q4 2024 earnings?

GeneDx Holdings (WGS) reported Q4 2024 earnings on February 18, 2025 before market open.

What were GeneDx Holdings's Q4 2024 revenue and EPS?

GeneDx Holdings reported revenue of $95.6M and eps of $0.70 for Q4 2024.

Did GeneDx Holdings beat estimates in Q4 2024?

Revenue beat the consensus estimate of $79.0M by $16.7M. EPS beat the consensus estimate of $0.04 by $0.66.

Where can I find GeneDx Holdings's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001818331-25-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.

GeneDx Holdings WGS Q4 2024 Annual earnings

Reported February 18, 2025 · Before market open

Revenue$95.6MBeat by $16.7M

EPS$0.70Beat by $0.66

Revenue estimate$79.0M

EPS estimate$0.04

Next report

Aug 3, 2026 (In 4 days)

Revenue estimate$111.0M

EPS estimate-$0.19

Financials

Q4 2024

Income statement

See full

Revenue$95.6M+66.6%

Gross profit$66.2M+115%

Balance sheet

See full

Cash & equivalents$86.2M-14.4%

Total debt$117.4M-2.0%

Total equity$245.2M+7.6%

Total assets$419.4M+0.1%

Cash flow

See full

Operating cash flow-$3.2M+89.3%

CapEx$3.1M+28.4%

Free cash flow-$6.2M+80.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.11B+2,866%

Enterprise value$2.14B+2,273%

P/S6.9×+6.6×

Profitability

See full

Gross margin63.6%+19.2pp

FCF margin-11.1%-5.2pp

Returns & leverage

See full

Debt / equity0.5×0.0×

Current ratio3.6×+0.5×

Versus estimates

Revenue

Q1 2026$102.3MMiss by $10.2M Q4 2025$121.0MBeat by $675.6K Q3 2025$116.7MMiss by $3.7M Q2 2025$102.7MBeat by $4.1M Q1 2025$87.1MBeat by $1.8M

Q4 2024$95.6MBeat by $16.7M

Diluted EPS

Q1 2026-$0.28Miss by $0.22 Q4 2025$0.14Beat by $0.03 Q3 2025$0.49Beat by $0.21 Q2 2025$0.50Beat by $0.40 Q1 2025$0.28Beat by $0.17

Q4 2024$0.70Beat by $0.66

Ask the moment GeneDx Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did GeneDx Holdings report Q4 2024 earnings?: GeneDx Holdings (WGS) reported Q4 2024 earnings on February 18, 2025 before market open.
What were GeneDx Holdings's Q4 2024 revenue and EPS?: GeneDx Holdings reported revenue of $95.6M and eps of $0.70 for Q4 2024.
Did GeneDx Holdings beat estimates in Q4 2024?: Revenue beat the consensus estimate of $79.0M by $16.7M. EPS beat the consensus estimate of $0.04 by $0.66.
Where can I find GeneDx Holdings's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001818331-25-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.